THE RENAL COMPOSITE BENEFITS ASSOCIATED WITH SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR IS ASSOCIATED WITH BACKGROUND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND NOT HEART FAILURE: A META-ANALYSIS

WCN23-0043
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
 
 
 
 
THE RENAL COMPOSITE BENEFITS ASSOCIATED WITH SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR IS ASSOCIATED WITH BACKGROUND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND NOT HEART FAILURE: A META-ANALYSIS
Ghosal, S.(1)*;Ghosal, A.(2);Ghosal, S.(3);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Nightingale Hospital, Endocrinology, Kolkata, India;(2)Nightingale Hospital, Internal Medicine, Kolkata, India;(3)Nightingale Hospital, Obstetric & Gynaecology, Kolkata, India;
https://storage.unitedwebnetwork.com/files/1041/9bdda0b85f3b6072f99569076bc8afc6.pdf
 
if any